{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:06:54Z","timestamp":1757700414489,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s12265-019-09931-z","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T16:02:30Z","timestamp":1573833750000},"page":"668-675","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Interaction Between Diabetes Mellitus and Platelet Reactivity in Determining Long-Term Outcomes Following Percutaneous Coronary Intervention"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3505-0716","authenticated-orcid":false,"given":"Fabio","family":"Mangiacapra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Bressi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iginio","family":"Colaiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Ricottini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Cavallari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marialessia","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele Matia","family":"Viscusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Spoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germano","family":"Di Sciascio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"9931_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann, F. J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., et al. (2019). 2018 ESC\/EACTS Guidelines on myocardial revascularization. European Heart Journal, 40, 87\u2013165.","journal-title":"European Heart Journal"},{"key":"9931_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.amjcard.2017.06.019","volume":"120","author":"B Redfors","year":"2017","unstructured":"Redfors, B., Ben-Yehuda, O., Lin, S. H., Furer, A., Kirtane, A. J., Witzenbichler, B., et al. (2017). Quantifying ischemic risk after percutaneous coronary intervention attributable to high platelet reactivity on Clopidogrel (from the assessment of dual antiplatelet therapy with drug-eluting stents study). The American Journal of Cardiology, 120, 917\u2013923.","journal-title":"The American Journal of Cardiology"},{"key":"9931_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s11239-018-1630-5","volume":"45","author":"F Mangiacapra","year":"2018","unstructured":"Mangiacapra, F., Colaiori, I., Ricottini, E., Creta, A., Di Gioia, G., Cavallari, I., et al. (2018). Impact of platelet reactivity on 5-year clinical outcomes following percutaneous coronary intervention: A landmark analysis. Journal of Thrombosis and Thrombolysis, 45, 496\u2013503.","journal-title":"Journal of Thrombosis and Thrombolysis"},{"key":"9931_CR4","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1161\/01.CIR.102.9.1014","volume":"102","author":"K Malmberg","year":"2000","unstructured":"Malmberg, K., Yusuf, S., Gerstein, H. C., Brown, J., Zhao, F., Hunt, D., et al. (2000). Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: Results of the OASIS (organization to assess strategies for ischemic syndromes) registry. Circulation, 102, 1014\u20131019.","journal-title":"Circulation"},{"key":"9931_CR5","doi-asserted-by":"publisher","first-page":"594","DOI":"10.21037\/cdt.2018.05.09","volume":"8","author":"JR Rivas Rios","year":"2018","unstructured":"Rivas Rios, J. R., Franchi, F., Rollini, F., & Angiolillo, D. J. (2018). Diabetes and antiplatelet therapy: From bench to bedside. Cardiovasc Diagn Ther, 8, 594\u2013609.","journal-title":"Cardiovasc Diagn Ther"},{"key":"9931_CR6","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.jacc.2014.06.1170","volume":"64","author":"DJ Angiolillo","year":"2014","unstructured":"Angiolillo, D. J., Jakubowski, J. A., Ferreiro, J. L., Tello-Montoliu, A., Rollini, F., Franchi, F., et al. (2014). Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease. Journal of the American College of Cardiology, 64, 1005\u20131014.","journal-title":"Journal of the American College of Cardiology"},{"key":"9931_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3109\/09537104.2013.824562","volume":"25","author":"F Mangiacapra","year":"2014","unstructured":"Mangiacapra, F., Peace, A., Barbato, E., Patti, G., Gatto, L., Ricottini, E., et al. (2014). Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitus. Platelets, 25, 348\u2013356.","journal-title":"Platelets"},{"key":"9931_CR8","doi-asserted-by":"crossref","unstructured":"Sweeny, J. M., Angiolillo, D. J., Franchi, F., Rollini, F., Waksman, R., Raveendran, G., et al. (2017). Impact of diabetes mellitus on the Pharmacodynamic effects of Ticagrelor versus Clopidogrel in troponin-negative acute coronary syndrome patients undergoing ad hoc percutaneous coronary intervention. Journal of the American Heart Association, 6.","DOI":"10.1161\/JAHA.117.005650"},{"key":"9931_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.amjcard.2010.04.015","volume":"106","author":"F Mangiacapra","year":"2010","unstructured":"Mangiacapra, F., Patti, G., Peace, A., Gatto, L., Vizzi, V., Ricottini, E., et al. (2010). Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention. The American Journal of Cardiology, 106, 619\u2013623.","journal-title":"The American Journal of Cardiology"},{"key":"9931_CR10","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.2337\/diacare.26.12.3331","volume":"26","author":"S Genuth","year":"2003","unstructured":"Genuth, S., Alberti, K. G., Bennett, P., Buse, J., Defronzo, R., Kahn, R., et al. (2003). Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 26, 3160\u20133167.","journal-title":"Diabetes Care"},{"key":"9931_CR11","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jcin.2012.01.009","volume":"5","author":"F Mangiacapra","year":"2012","unstructured":"Mangiacapra, F., Patti, G., Barbato, E., Peace, A. J., Ricottini, E., Vizzi, V., et al. (2012). A therapeutic window for platelet reactivity for patients undergoing elective percutaneous coronary intervention: Results of the ARMYDA-PROVE (antiplatelet therapy for reduction of MYocardial damage during angioplasty-platelet reactivity for outcome validation effort) study. JACC. Cardiovascular Interventions, 5, 281\u2013289.","journal-title":"JACC. Cardiovascular Interventions"},{"key":"9931_CR12","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"72","author":"K Thygesen","year":"2018","unstructured":"Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., et al. (2018). Fourth universal definition of myocardial infarction (2018). Journal of the American College of Cardiology, 72, 2231\u20132264.","journal-title":"Journal of the American College of Cardiology"},{"key":"9931_CR13","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","volume":"115","author":"DE Cutlip","year":"2007","unstructured":"Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G. A., et al. (2007). Clinical end points in coronary stent trials: A case for standardized definitions. Circulation, 115, 2344\u20132351.","journal-title":"Circulation"},{"key":"9931_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","volume":"66","author":"KA Hicks","year":"2015","unstructured":"Hicks, K. A., Tcheng, J. E., Bozkurt, B., Chaitman, B. R., Cutlip, D. E., Farb, A., et al. (2015). 2014 ACC\/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: A report of the American College of Cardiology\/American Heart Association task force on clinical data standards (writing committee to develop cardiovascular endpoints data standards). Journal of the American College of Cardiology, 66, 403\u2013469.","journal-title":"Journal of the American College of Cardiology"},{"key":"9931_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","volume":"11","author":"AK Rao","year":"1988","unstructured":"Rao, A. K., Pratt, C., Berke, A., Jaffe, A., Ockene, I., Schreiber, T. L., et al. (1988). Thrombolysis in myocardial infarction (TIMI) trial--phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. Journal of the American College of Cardiology, 11, 1\u201311.","journal-title":"Journal of the American College of Cardiology"},{"key":"9931_CR16","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","volume":"287","author":"JA Beckman","year":"2002","unstructured":"Beckman, J. A., Creager, M. A., & Libby, P. (2002). Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA, 287, 2570\u20132581.","journal-title":"JAMA"},{"key":"9931_CR17","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.amjcard.2018.02.034","volume":"121","author":"SH Pi","year":"2018","unstructured":"Pi, S. H., Rhee, T. M., Lee, J. M., Hwang, D., Park, J., Park, T. K., et al. (2018). Outcomes in patients with diabetes mellitus according to insulin treatment after percutaneous coronary intervention in the second-generation drug-eluting stent era. The American Journal of Cardiology, 121, 1505\u20131511.","journal-title":"The American Journal of Cardiology"},{"key":"9931_CR18","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.2337\/diabetes.54.8.2430","volume":"54","author":"DJ Angiolillo","year":"2005","unstructured":"Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Ram\u00edrez, C., Sabat\u00e9, M., Jimenez-Quevedo, P., et al. (2005). Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment. Diabetes, 54, 2430\u20132435.","journal-title":"Diabetes"},{"key":"9931_CR19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jacc.2006.03.038","volume":"48","author":"DJ Angiolillo","year":"2006","unstructured":"Angiolillo, D. J., Bernardo, E., Ram\u00edrez, C., Costa, M. A., Sabat\u00e9, M., Jimenez-Quevedo, P., et al. (2006). Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment. Journal of the American College of Cardiology, 48, 298\u2013304.","journal-title":"Journal of the American College of Cardiology"},{"key":"9931_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jacc.2018.11.001","volume":"73","author":"ME Farkouh","year":"2019","unstructured":"Farkouh, M. E., Domanski, M., Dangas, G. D., Godoy, L. C., Mack, M. J., Siami, F. S., et al. (2019). Long-term survival following multivessel revascularization in patients with diabetes: The FREEDOM follow-on study. Journal of the American College of Cardiology, 73, 629\u2013638.","journal-title":"Journal of the American College of Cardiology"},{"key":"9931_CR21","first-page":"3","volume":"16","author":"A Le Bras","year":"2019","unstructured":"Le Bras, A. (2019). Long-term mortality benefit of CABG surgery over PCI in patients with diabetes mellitus. Nature Reviews. Cardiology, 16, 3.","journal-title":"Nature Reviews. Cardiology"},{"key":"9931_CR22","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/eurheartj\/ehx138","volume":"38","author":"R Cavalcante","year":"2017","unstructured":"Cavalcante, R., Sotomi, Y., Mancone, M., Whan Lee, C., Ahn, J. M., Onuma, Y., et al. (2017). Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: A pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials. European Heart Journal, 38, 1969\u20131977.","journal-title":"European Heart Journal"},{"key":"9931_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4244\/EIJV12I3A51","volume":"12","author":"S De Servi","year":"2016","unstructured":"De Servi, S., Crimi, G., Calabr\u00f2, P., Piscione, F., Cattaneo, M., Maffeo, D., et al. (2016). Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. EuroIntervention, 12, 312\u2013318.","journal-title":"EuroIntervention"},{"key":"9931_CR24","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.jacc.2014.01.064","volume":"63","author":"E Kedhi","year":"2014","unstructured":"Kedhi, E., G\u00e9n\u00e9reux, P., Palmerini, T., McAndrew, T. C., Parise, H., Mehran, R., et al. (2014). Impact of coronary lesion complexity on drug-eluting stent outcomes in patients with and without diabetes mellitus: Analysis from 18 pooled randomized trials. Journal of the American College of Cardiology, 63, 2111\u20132118.","journal-title":"Journal of the American College of Cardiology"},{"key":"9931_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11239-010-0547-4","volume":"32","author":"F Mangiacapra","year":"2011","unstructured":"Mangiacapra, F., Peace, A. J., Wijns, W., & Barbato, E. (2011). Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel. Journal of Thrombosis and Thrombolysis, 32, 54\u201358.","journal-title":"Journal of Thrombosis and Thrombolysis"},{"key":"9931_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1160\/TH15-12-0981","volume":"116","author":"ET Carreras","year":"2016","unstructured":"Carreras, E. T., Hochholzer, W., Frelinger, A. L., Nordio, F., O\u2019Donoghue, M. L., Wiviott, S. D., et al. (2016). Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel. Insights from the ELEVATE-TIMI 56 trial. Thrombosis and Haemostasis, 116, 69\u201377.","journal-title":"Thrombosis and Haemostasis"},{"key":"9931_CR27","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.jcin.2014.04.020","volume":"7","author":"T Palmerini","year":"2014","unstructured":"Palmerini, T., Calabr\u00f2, P., Piscione, F., De Servi, S., Cattaneo, M., Maffeo, D., et al. (2014). Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study. JACC. Cardiovascular Interventions, 7, 1117\u20131127.","journal-title":"JACC. Cardiovascular Interventions"},{"key":"9931_CR28","doi-asserted-by":"publisher","first-page":"E369","DOI":"10.1002\/ccd.27921","volume":"93","author":"E Fabris","year":"2019","unstructured":"Fabris, E., Van\u2019t Hof, A., Hamm, C. W., Lapostolle, F., Lassen, J. F., Goodman, S. G., et al. (2019). Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trial. Catheterization and Cardiovascular Interventions, 93, E369\u2013E377.","journal-title":"Catheterization and Cardiovascular Interventions"},{"key":"9931_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijcard.2018.10.071","volume":"275","author":"M Faggioni","year":"2019","unstructured":"Faggioni, M., Baber, U., Chandrasekhar, J., Sartori, S., Claessen, B. E., Rao, S. V., et al. (2019). Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention. International Journal of Cardiology, 275, 31\u201335.","journal-title":"International Journal of Cardiology"},{"key":"9931_CR30","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1161\/CIRCULATIONAHA.116.023743","volume":"134","author":"F Mangiacapra","year":"2016","unstructured":"Mangiacapra, F., Panaioli, E., Colaiori, I., Ricottini, E., Lauria Pantano, A., Pozzilli, P., et al. (2016). Clopidogrel versus Ticagrelor for antiplatelet maintenance in diabetic patients treated with percutaneous coronary intervention: Results of the CLOTILDIA study (Clopidogrel high dose versus Ticagrelor for antiplatelet maintenance in diabetic patients). Circulation, 134, 835\u2013837.","journal-title":"Circulation"},{"key":"9931_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jacc.2016.04.039","volume":"68","author":"F Mangiacapra","year":"2016","unstructured":"Mangiacapra, F., Di Gioia, G., Pellicano, M., Di Serafino, L., Bressi, E., Peace, A. J., et al. (2016). Effects of Prasugrel versus Clopidogrel on coronary microvascular function in patients undergoing elective PCI. Journal of the American College of Cardiology, 68, 235\u2013237.","journal-title":"Journal of the American College of Cardiology"},{"key":"9931_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2018.08.044","volume":"278","author":"F Mangiacapra","year":"2018","unstructured":"Mangiacapra, F., Pellicano, M., Di Serafino, L., Bressi, E., Peace, A. J., Di Gioia, G., et al. (2018). Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel. Atherosclerosis, 278, 23\u201328.","journal-title":"Atherosclerosis"},{"key":"9931_CR33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/cvr\/cvy295","volume":"115","author":"KL Chin","year":"2019","unstructured":"Chin, K. L., Ofori-Asenso, R., Hopper, I., von Lueder, T. G., Reid, C. M., Zoungas, S., et al. (2019). Potential mechanisms underlying the cardiovascular benefits of sodium glucose cotransporter 2 inhibitors: A systematic review of data from preclinical studies. Cardiovascular Research, 115, 266\u2013276.","journal-title":"Cardiovascular Research"},{"key":"9931_CR34","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1016\/j.jacc.2018.09.020","volume":"72","author":"SR Das","year":"2018","unstructured":"Das, S. R., Everett, B. M., Birtcher, K. K., Brown, J. M., Cefalu, W. T., Januzzi, J. L., et al. (2018). 2018 ACC expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease: A report of the American College of Cardiology Task Force on expert consensus decision pathways. Journal of the American College of Cardiology, 72, 3200\u20133223.","journal-title":"Journal of the American College of Cardiology"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-019-09931-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12265-019-09931-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-019-09931-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:36:29Z","timestamp":1605314189000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12265-019-09931-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["9931"],"URL":"https:\/\/doi.org\/10.1007\/s12265-019-09931-z","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"type":"print","value":"1937-5387"},{"type":"electronic","value":"1937-5395"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"assertion":[{"value":"18 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}